Prescribing Asthma Controller Medication According to Gene Status to Improve Quality of Life in Young People With Asthma

NCT02758873 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

241

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

GENETIC: Personalised medicine (Salmeterol)
GENETIC: Personalised medicine (Montelukast)
OTHER: Standard care

Sponsor

University of Sussex